• 10:00
    Start and introduction by Hilde Holme
  • -
    Product Development by Hilde Holme
  • -
    Quality Target Product Profile by Marianne Ammitzbøll
  • -
    CMC Documentation & Roadmap by Hilde Foros and Lone Dyrby
  • -
    Summary by Lone Dyrby​
  • 10:30
  • 10:45

    The Importance of Regulatory CMC Strategy During Early Development

    starts:09/02/2023 ends:09/02/2023 from:10:00 to:10:45 organizer: address:webinar via Zoom www: Link >> Import to calendar

    Venue: webinar via Zoom

    Date: 09/02/2023

    Time: 10:00 - 10:45

    Accelerate development using a Quality Target Product Profile

    Having the right Chemistry, Manufacturing, and Controls (CMC) documentation throughout drug development is essential for avoiding pitfalls, ensuring an efficient regulatory review process, and achieving the goals for your product. The key is an early development regulatory strategy that includes CMC.

    Join our regulatory CMC webinar to strengthen your knowledge of how regulatory CMC strategies can accelerate the drug development process and become familiar with strategic tools such as the Quality Target Product Profile (QTPP).

    If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 7172 1114

    Copyright 2023 DANISH BIO – DANSK BIOTEK. All rights reserved.